How long should we fear? Long-term risk of venous thromboembolism in patients with traumatic brain injury.

How long should we fear? Long-term risk of venous thromboembolism in patients with traumatic brain injury.

Venous thromboembolism (VTE) constitutes an undesirable outcome in the care of trauma patients. In the United States, the annual healthcare costs associated with VTE is estimated at $1.5 billion(1) and close to 100,000 people die from VTE yearly.(2) Among trauma patients who develop pulmonary emboli...

Full description

Bibliographic Details
Main Authors:	Olubode, O, Yorkgitis, B, Metcalfe, D, Rios Diaz, A, Haider, A, Havens, J, Cooper, Z, Kelly, E, Gates, J, Salim, A
Format:	Journal article
Published:	Lippincott, Williams andamp; Wilkins: No Hybrid Open Access 2016

Similar Items

Do transferred patients increase the risk of venous thromboembolism in trauma centers?
by: Yorkgitis, BK, et al.
Published: (2017)

Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?
by: Giuseppe Camporese, et al.
Published: (2021-01-01)

Are appendectomy outcomes in level 1 trauma centers as good as we think?
by: Metcalfe, D, et al.
Published: (2016)

SHOULD WE FEAR CHINA?
by: Benoni Andronic, et al.
Published: (2020-06-01)

Correlation Study of the Long-Term Prognosis of Venous Thromboembolism and Inflammatory Gene Polymorphisms
by: Abuduhalike R, et al.
Published: (2020-12-01)

Whatever happens to trauma patients who leave against medical advice?
by: Olufajo, O, et al.
Published: (2015)

The truth about trauma readmissions
by: Olufajo, O, et al.
Published: (2015)

Prepregnancy overweight and obesity and long-term risk of venous thromboembolism in women
by: Ahmad Mahmoud, et al.
Published: (2023-09-01)

How we changed our approach to venous thromboembolism
by: Walter Ageno
Published: (2022-10-01)

The Trans-Pacific Partnership: Should We “Fear the Fear”?; Comment on “The Trans-Pacific Partnership: Is It Everything We Feared for Health?”
by: Helen L. Walls, et al.
Published: (2017-06-01)

Venous thromboembolic events in isolated severe traumatic brain injury
by: Shahin Mohseni, et al.
Published: (2012-01-01)

What should a general practitioner know about the management of patients with venous thromboembolism?
by: S. M. Markin, et al.
Published: (2023-10-01)

Preeclampsia and venous thromboembolism
by: K. N. Grigoreva, et al.
Published: (2022-07-01)

Economic Analysis of Rivaroxaban for the Treatment and Long-Term Prevention of Venous Thromboembolism in Portugal
by: Isabel Fonseca Santos, et al.
Published: (2014-10-01)

Long-Term Incidence of Venous Thromboembolism in Cancer: The Scandinavian Thrombosis and Cancer Cohort
by: Inger Lise Gade, et al.
Published: (2018-04-01)

Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism
by: Liew, Ngoh Chin, et al.
Published: (2017)

Retrospective evaluation of chemical venous thromboembolism prophylaxis in traumatic brain injury
by: Emily K. Hollfelder, et al.
Published: (2023-06-01)

Venous thromboembolism
by: Wang Chunmei
Published: (2024-07-01)

Examining the long-term effects of traumatic brain injury on fear extinction in male rats
by: K. A. Smith, et al.
Published: (2023-06-01)

Venous thromboembolism in Portuguese hospitals: Where we stand and how we can improve
by: Graça Castro
Published: (2017-11-01)

Venous anomalies and thromboembolism
by: Caroline Dix, et al.
Published: (2023-04-01)

Risk of Venous Thromboembolism in Patients Nursed at Home or in Long-Term Care Residential Facilities
by: Guido Arpaia, et al.
Published: (2011-01-01)

Prevalence and incidence of venous thromboembolism in geriatric patients admitted to long-term care hospitals
by: Gernot Wagner, et al.
Published: (2024-07-01)

Comparison of long-term complications in cancer patients with incidental and acute symptomatic venous thromboembolism
by: María Barca-Hernando, et al.
Published: (2023-05-01)

Management of intracranial tuberculous mass lesions: How long should we treat for?
by: Marais, S, et al.
Published: (2019)

Introduction to venous thromboembolism and prophylaxis
by: Howard, A, et al.
Published: (2006)

Post-stroke psychosis: how long should we treat?
by: Maria do Céu Ferreira, et al.
Published: (2017-06-01)

EFFECT OF LONG-TERM ENOXAPARIN THERAPY ON RISK OF RECURRENT VENOUS THROMBOEMBOLIC COMPLICATIONS AND RECANALIZATION OFTHROMBOSED VEINS
by: N. M. Vorobyova, et al.
Published: (2015-12-01)

Should we use prognostic scores for acute pulmonary thromboembolism in clinical practice?
by: Marcelo Basso Gazzana, et al.
Published: (2019-02-01)

Which activities do those with long commutes forego, and should we care?
by: Eric A. Morris, et al.
Published: (2020-05-01)

Venous thromboembolism in surgical practice.
by: I. L. Verkholaz, et al.
Published: (2018-12-01)

Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era
by: Toth PP
Published: (2016-02-01)

Homoarginine and methylarginines independently predict long-term outcome in patients presenting with suspicion of venous thromboembolism
by: Roman N. Rodionov, et al.
Published: (2021-05-01)

Aspirin for Venous Thromboembolism Prophylaxis and Nonsteroidal Anti-inflammatory Agents Should Be Administered at Least 2 Hours Apart
by: Matthew J. Grosso, MD
Published: (2025-04-01)

Venous thromboembolic complications
by: G. G. Khubulava, et al.
Published: (2019-02-01)

THALASSEMIA AND VENOUS THROMBOEMBOLISM
by: Julien Succar, et al.
Published: (2011-05-01)

THALASSEMIA AND VENOUS THROMBOEMBOLISM
by: Khaled M. Musallam, et al.
Published: (2011-01-01)

Osteoporosis and venous thromboembolism
by: Irina Aleksandrovna Baranova, et al.
Published: (2011-02-01)

Hyperglycemia and Venous Thromboembolism
by: Neha Panchagnula, et al.
Published: (2024-09-01)

Approach to: Venous Thromboembolism
by: Salima Ramdani
Published: (2022-10-01)